What is the recommended dose of lorazepam (Ativan) given sublingually (SL) for seizure management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing of Sublingual Lorazepam for Seizure Management

For seizure management in adults, the recommended sublingual (SL) lorazepam dose is 1 mg (range 0.5-2 mg), which has shown effectiveness in controlling prolonged and repetitive seizures without serious adverse events. 1

Dosing Recommendations by Age Group

Adults:

  • Initial dose: 1 mg SL (range 0.5-2 mg)
  • May repeat if seizures continue after 10-15 minutes
  • Maximum total dose: 2 mg per episode

Children:

  • Dose range: 0.05-0.15 mg/kg SL 2
  • Typical effective dose: 0.1 mg/kg SL
  • Maximum single dose: 4 mg

Administration Guidelines

  1. Preparation:

    • Use lorazepam oral concentrate solution
    • Place directly under the tongue
    • Have patient/caregiver hold solution under tongue until absorbed
    • Do not swallow immediately
  2. Timing:

    • Administer as soon as possible for prolonged seizures (>5 minutes)
    • For repetitive seizures, administer after the first seizure to prevent subsequent episodes
  3. Storage considerations:

    • Lorazepam solution typically requires refrigeration
    • This can limit accessibility in emergency situations 1
    • Consider portable cooling options if refrigeration limits access

Efficacy Data

Sublingual lorazepam has demonstrated good efficacy in seizure management:

  • 70% effectiveness in stopping prolonged seizures within 5 minutes
  • 66% effectiveness in preventing further seizures in patients with repetitive seizure patterns 1

For comparison, IV lorazepam at the recommended dose of 0.05-0.1 mg/kg (maximum 4 mg) has shown:

  • 76% efficacy in controlling seizures with a single dose 3
  • Significantly higher rates of refractory status epilepticus when underdosed 4

Safety Considerations

Common Side Effects:

  • Sedation (31% of patients may develop moderate/severe sedation) 1
  • Drowsiness
  • Unsteadiness

Serious Adverse Events:

  • Respiratory depression (less common with SL than IV administration)
  • Risk of respiratory depression increases when combined with other sedative agents 5

Important Precautions:

  • Monitor respiratory status after administration
  • Be prepared to provide respiratory support if needed
  • Flumazenil may be administered to reverse life-threatening respiratory depression, but this will also counteract the anticonvulsant effects and may precipitate recurrence of seizures 5

Clinical Pearls

  1. Sublingual lorazepam offers an accessible alternative to rectal diazepam or expensive intranasal formulations for home management of seizures.

  2. Patient/caregiver education is essential for proper administration and monitoring.

  3. The need for refrigeration is a significant limitation, with 44% of patients reporting this limited treatment access 1.

  4. Having this emergency treatment available provides psychological benefit, with 79% of patients reporting increased feelings of safety 1.

  5. Underdosing lorazepam for seizure management is associated with progression to refractory status epilepticus, emphasizing the importance of appropriate dosing 4.

Sublingual lorazepam represents a practical, effective option for acute seizure management, particularly in settings where IV access is challenging or unavailable.

References

Research

Sublingual lorazepam in childhood serial seizures.

American journal of diseases of children (1960), 1988

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.